Search

ABDO announces groundbreaking therapy for contact lens opticians

The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...

BCLA Presidential Address highlights the opportunities for growth in contact lens sector

The new President of the BCLA has used his inaugural address to urge the sector to have “meaningful” conversations after eye exams and deliver “better vision outcomes” for patients.

SPOKE launches Indicative Guidance for contact lens opticians and independent prescribers

The Sector Partnership for Optical Knowledge and Education (SPOKE) has published two new Indicative Guidance documents.

MCLOSA (Medical Contact Lens and Ocular Surface Association) Meeting 2024

BCLA (British Contact Lens Association) Clinical Conference & Exhibition

The BCLA hosts the UK’s largest Clinical Conference & Exhibition dedicated to contact lenses and the anterior eye every 2 years. This highly regarded three-day event will be returning to Birmingham in 2025 on 5 - 7 June with the...

‘Agenda-setting’ BCLA Clinical Conference to shape the future of contact lens practice around the world

The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.

ABDO gains GOC approval to begin delivering new diploma in contact lens practice syllabus

The Association of British Dispensing Opticians (ABDO) has received approval from the General Optical Council (GOC) to begin delivering the Diploma in Contact Lens Practice syllabus from September 2024. As the awarding organisation, ABDO will be working in partnership with two education centres, ABDO College and Bradford College.

First UK Direct Selective Laser Trabeculoplasty (DSLT) device placed at Moorfields

Following an internationally successful Randomised Controlled Trial (RCT) comparing the Direct Selective Laser Trabeculoplasty (DSLT) with standard SLT, the first ever commercial device in the UK, the ‘Eagle’, has been installed and is in use at Moorfields Eye Hospital in London.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.